⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13435199 | 1.00 | — | — | |
| SCHEMBL5870085 | 0.88 | ARG1 (0.31) | — | |
| SCHEMBL5617760 | 0.75 | — | — | |
| SCHEMBL23115271 | 0.75 | POLB (0.30) | — | |
| SCHEMBL28875199 | 0.75 | — | — | |
| SCHEMBL8701041 | 0.73 | — | — | |
| SCHEMBL11391091 | 0.71 | USP2 (0.31) | — | |
| SCHEMBL3485597 | 0.71 | — | — | |
| SCHEMBL7552953 | 0.71 | MEN1 (0.30) | — | |
| SCHEMBL24446257 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1272843-B1 | METHOD FOR IDENTIFYING REGULATORS OF PROTEIN-AGE FORMATION | NIADYNE CORP (US) | 2007-06-20 | — | — | EP | disclosed |
| CN-1205480-C | Method for identifying regulators of protein-AGE formation | NLADYNE CORP (US) | 2005-06-08 | — | — | CN | disclosed |
| EP-1274418-A4 | METHODS OF USE OF PENICILLAMINES FOR THE TREATMENT OF CONDITIONS RESULTING FROM DNA DAMAGE | NIADYNE CORP (US) | 2005-02-09 | — | — | EP | disclosed |
| US-6716635-B2 | MIXING A SUBSTANCE TO BE TESTED, A HISTONE H1 AND ADP-RIBOSE AND MEASURING THE FLUORESCENCE AND PROTEIN CROSSLINKING; COMBINATORIAL LIBRARIES; ANTIDIABETIC AGENTS; ATHEROSCLEROSIS, CHRONIC NEURODEGENERATIVE DISEASES, E.G.,ALZHEIMER'S; | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION | 2004-04-06 | — | — | US | disclosed |
| CN-1451096-A | Method for identifying regulators of protein-AGE formation | NIADYNE CORP (US) | 2003-10-22 | — | — | CN | disclosed |
| EP-1274418-A1 | METHODS OF USE OF PENICILLAMINES FOR THE TREATMENT OF CONDITIONS RESULTING FROM DNA DAMAGE | Niadyne Corporation (US) | 2003-01-15 | — | — | EP | disclosed |
| EP-1272843-A2 | METHOD FOR IDENTIFYING REGULATORS OF PROTEIN-AGE FORMATION | Niadyne Corporation (US) | 2003-01-08 | — | — | EP | disclosed |
| US-20020156134-A1 | Method and use of alpha-amino-beta-mercapto-ethane derivatives as dicarbonyl scavengers for treatment of conditions resulting from protein, lipid, and DNA damage | JACOBSON ELAINE L (US) | 2002-10-24 | — | — | US | disclosed |
| US-6417235-B2 | INHIBITING PRODUCTION OF ADVANCED GLYCOSYLATION END PRODUCTS IN A PATIENT COMPRISING ADMINISTERING TO THE PATIENT D-PENICILLAMINE, L-PENICILLAMINE, AND D,L-PENICILLAMINE | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION | 2002-07-09 | — | — | US | disclosed |
| US-20020037496-A1 | Method for identifying regulators of protein-advanced glycation end product (protein-AGE) formation | NIADYNE, INC. | 2002-03-28 | — | — | US | disclosed |
| US-20010051658-A1 | Method and use of penicillamines and other alpha-amino-beta,beta-mercapto-beta,beta-dimethyl-ethane derivatives as dicarbonyl scavengers for treatment of conditions resulting from protein, lipid, and DNA damage | NIADYNE, INC. | 2001-12-13 | — | — | US | disclosed |
| WO-2001078718-A1 | METHODS OF USE OF PENICILLAMINES FOR THE TREATMENT OF CONDITIONS RESULTING FROM DNA DAMAGE | NIADYNE CORPORATION (US) | 2001-10-25 | — | — | WO | disclosed |
| WO-2001079842-A2 | METHOD FOR IDENTIFYING REGULATORS OF PROTEIN-AGE FORMATION | NIADYNE CORPORATION (US) | 2001-10-25 | — | — | WO | disclosed |